NCT03565211 - Clinical Safety Study of the Progesterone Vaginal Ring in Women Undergoing Assisted Reproductive Technology Procedures | Biotech Hunter

Enrollment

352

Participants

Timeline

Start Date

July 26, 2018

Primary Completion Date

July 29, 2019

Study Completion Date

July 29, 2019

Conditions

Progesterone Supplementation in Women Undergoing ART

Interventions

DRUG

Progesterone vaginal ring

A flexible, non-degradable PVR containing progesterone in micronized formulation and dispersed evenly throughout the ring.

Trial Locations (15)

Main Line Fertility Center, Bryn Mawr

Abington Reproductive Medicine, Abington

Reproductive Associates of DE, Newark

Carolina Conceptions, Raleigh

Center for Reproductive Medicine, Winter Park

Women's Medical Research Group, Clearwater

InVia Fertility, Hoffman Estates

Center for Assisted Reproduction, Bedford

Houston Fertility Institute, Houston

Center of Reproductive Medicine, Webster

Idaho Center for Reproductive Medicine, Boise

Utah Fertility Center, Pleasant Grove

Fertility Treatment Center, Tempe

HRC Fertility, Encino

"Eastern Virginia Medical School , EVMS Obstetrics & Gynecology"